Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Online Network.
Press releases published on June 27, 2025

NPL Home Medical Named Winner of The Northeast Ohio Top Worplaces Award
NPL Home Medical specializes in providing high-quality,custom wheelchairs and has been awarded a Top Workplaces 2025 honor by cleveland.com and The Plain Dealer STRONGSVILLE, OH, UNITED STATES, June 27, 2025 /EINPresswire.com/ -- NPL Home Medical, a …

Ultrasonic Position Sensor Market to Observe Strong Development by 2032
Ultrasonic Position Sensor Market Expected to Reach $140.9 Million by 2032 WILMINGTON, DE, UNITED STATES, June 27, 2025 /EINPresswire.com/ -- The global ultrasonic position sensor market share is expected to witness considerable growth, owing to the …

Dr. Mohana Rao Patibandla Unveils Groundbreaking Neuroendoport Study at NSI YNF Conference
Dr. Mohana Rao Patibandla Unveils Groundbreaking Neuroendoport Study at NSI YNF Conference GUNTUR, ANDHRA PRADESH, INDIA, June 27, 2025 /EINPresswire.com/ -- Dr. Mohana Rao Patibandla Unveils Groundbreaking Neuroendoport Study at NSI Conference …

Medical Supplierz Sets New Standards for B2B Medical Equipment Marketplaces
KUWAIT, KUWAIT, June 27, 2025 /EINPresswire.com/ -- Medical Supplierz, a digital B2B platform focused on healthcare procurement, is introducing new operational standards for how medical equipment is traded internationally. By addressing inefficiencies in …

AVACEN Announces Two New Patent Approvals for CATHSTA Device in Rapid Succession
Designed to improve catheter stability during complex cardiac procedures CARLSBAD, CA, UNITED STATES, June 26, 2025 /EINPresswire.com/ -- AVACEN, Inc., a leader in non-invasive medical device innovation, announced today that it has received two major …

Kymera Therapeutics Announces Pricing of $250 Million Public Offering
WATERTOWN, Mass., June 26, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced the pricing …

Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering
SEATTLE and VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …